MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a leading pre-clinical-stage pharmaceutical development company, is excited to announce that its novel oral ketamine analog, Ketamir-2, has shown greater pain ...

Mira Murati want to co,pete in the AI world. A first round of investment is reportedly already underway. Mira Murati has ...

The Magical Girl and the Evil Lieutenant Used to be Archenemies is translated by Giuseppe di Martino and lettered by Rochelle ...

Murati left her position as chief technology officer of the world’s best-known AI company at the end of September. She's now seeking $100 million in funding for her own venture.

Mira Bhayandar: In an attempt to ensure that lives of citizens are not put at risk this festive season the Mira Bhayandar ...

The fashion influencer and beauty brand entrepreneur is much more than icon. She is a well-known foodie and a passionate cook ...

Mira Murati, who recently left OpenAI, is to raise money for a new AI start-up with former colleagues.

Mira Murati, the former chief technology officer at OpenAI is in the process of raising capital for her new artificial intelligence startup, according to source ...

Former OpenAI CTO Mira Murati is reportedly raising funds from venture capitalists for her new startup. All you need to know.

MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a preclinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...

The Maharashtra Real Estate Regulatory Authority's Conciliation Forums have successfully resolved 30% of homebuyer complaints ...